Antiglioma Potential of Coumarins Combined with Sorafenib

Coumarins, which occur naturally in the plant kingdom, are diverse class of secondary metabolites. With their antiproliferative, chemopreventive and antiangiogenetic properties, they can be used in the treatment of cancer. Their therapeutic potential depends on the type and location of the attachmen...

Full description

Bibliographic Details
Main Authors: Joanna Sumorek-Wiadro, Adrian Zając, Ewa Langner, Krystyna Skalicka-Woźniak, Aleksandra Maciejczyk, Wojciech Rzeski, Joanna Jakubowicz-Gil
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/21/5192
_version_ 1797548561833918464
author Joanna Sumorek-Wiadro
Adrian Zając
Ewa Langner
Krystyna Skalicka-Woźniak
Aleksandra Maciejczyk
Wojciech Rzeski
Joanna Jakubowicz-Gil
author_facet Joanna Sumorek-Wiadro
Adrian Zając
Ewa Langner
Krystyna Skalicka-Woźniak
Aleksandra Maciejczyk
Wojciech Rzeski
Joanna Jakubowicz-Gil
author_sort Joanna Sumorek-Wiadro
collection DOAJ
description Coumarins, which occur naturally in the plant kingdom, are diverse class of secondary metabolites. With their antiproliferative, chemopreventive and antiangiogenetic properties, they can be used in the treatment of cancer. Their therapeutic potential depends on the type and location of the attachment of substituents to the ring. Therefore, the aim of our study was to investigate the effect of simple coumarins (osthole, umbelliferone, esculin, and 4-hydroxycoumarin) combined with sorafenib (specific inhibitor of Raf (Rapidly Accelerated Fibrosarcoma) kinase) in programmed death induction in human glioblastoma multiforme (T98G) and anaplastic astrocytoma (MOGGCCM) cells lines. Osthole and umbelliferone were isolated from fruits: <i>Mutellina purpurea</i> L. and <i>Heracleum leskowii</i> L., respectively, while esculin and 4-hydroxycoumarin were purchased from Sigma Aldrich (St. Louis, MO, USA). Apoptosis, autophagy and necrosis were identified microscopically after straining with specific fluorochromes. The level of caspase 3, Beclin 1, PI3K (Phosphoinositide 3-kinase), and Raf kinases were estimated by immunoblotting. Transfection with specific siRNA (small interfering RNA) was used to block Bcl-2 (B-cell lymphoma 2), Raf, and PI3K expression. Cell migration was tested with the wound healing assay. The present study has shown that all the coumarins eliminated the MOGGCCM and T98G tumor cells mainly via apoptosis and, to a lesser extent, via autophagy. Osthole, which has an isoprenyl moiety, was shown to be the most effective compound. Sorafenib did not change the proapoptotic activity of this coumarin; however, it reduced the level of autophagy. At the molecular level, the induction of apoptosis was associated with a decrease in the expression of PI3K and Raf kinases, whereas an increase in the level of Beclin 1 was observed in the case of autophagy. Inhibition of the expression of this protein by specific siRNA eliminated autophagy. Moreover, the blocking of the expression of Bcl-2 and PI3K significantly increased the level of apoptosis. Osthole and sorafenib successfully inhibited the migration of the MOGGCCM and T98G cells.
first_indexed 2024-03-10T15:01:17Z
format Article
id doaj.art-9bafea06528243acb145fcfd1be3ccf8
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T15:01:17Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-9bafea06528243acb145fcfd1be3ccf82023-11-20T20:10:40ZengMDPI AGMolecules1420-30492020-11-012521519210.3390/molecules25215192Antiglioma Potential of Coumarins Combined with SorafenibJoanna Sumorek-Wiadro0Adrian Zając1Ewa Langner2Krystyna Skalicka-Woźniak3Aleksandra Maciejczyk4Wojciech Rzeski5Joanna Jakubowicz-Gil6Department of Functional Anatomy and Cytobiology, Maria Curie-Sklodowska University, Akademicka 19, 20-033 Lublin, PolandDepartment of Functional Anatomy and Cytobiology, Maria Curie-Sklodowska University, Akademicka 19, 20-033 Lublin, PolandDepartment of Medical Biology, Institute of Rural Health, Institute of Agricultural Medicine, Jaczewskiego 2, 20-950 Lublin, PolandIndependent Laboratory of Natural Products, Medical University of Lublin, Chodzki 1, 20-093 Lublin, PolandDepartment of Functional Anatomy and Cytobiology, Maria Curie-Sklodowska University, Akademicka 19, 20-033 Lublin, PolandDepartment of Functional Anatomy and Cytobiology, Maria Curie-Sklodowska University, Akademicka 19, 20-033 Lublin, PolandDepartment of Functional Anatomy and Cytobiology, Maria Curie-Sklodowska University, Akademicka 19, 20-033 Lublin, PolandCoumarins, which occur naturally in the plant kingdom, are diverse class of secondary metabolites. With their antiproliferative, chemopreventive and antiangiogenetic properties, they can be used in the treatment of cancer. Their therapeutic potential depends on the type and location of the attachment of substituents to the ring. Therefore, the aim of our study was to investigate the effect of simple coumarins (osthole, umbelliferone, esculin, and 4-hydroxycoumarin) combined with sorafenib (specific inhibitor of Raf (Rapidly Accelerated Fibrosarcoma) kinase) in programmed death induction in human glioblastoma multiforme (T98G) and anaplastic astrocytoma (MOGGCCM) cells lines. Osthole and umbelliferone were isolated from fruits: <i>Mutellina purpurea</i> L. and <i>Heracleum leskowii</i> L., respectively, while esculin and 4-hydroxycoumarin were purchased from Sigma Aldrich (St. Louis, MO, USA). Apoptosis, autophagy and necrosis were identified microscopically after straining with specific fluorochromes. The level of caspase 3, Beclin 1, PI3K (Phosphoinositide 3-kinase), and Raf kinases were estimated by immunoblotting. Transfection with specific siRNA (small interfering RNA) was used to block Bcl-2 (B-cell lymphoma 2), Raf, and PI3K expression. Cell migration was tested with the wound healing assay. The present study has shown that all the coumarins eliminated the MOGGCCM and T98G tumor cells mainly via apoptosis and, to a lesser extent, via autophagy. Osthole, which has an isoprenyl moiety, was shown to be the most effective compound. Sorafenib did not change the proapoptotic activity of this coumarin; however, it reduced the level of autophagy. At the molecular level, the induction of apoptosis was associated with a decrease in the expression of PI3K and Raf kinases, whereas an increase in the level of Beclin 1 was observed in the case of autophagy. Inhibition of the expression of this protein by specific siRNA eliminated autophagy. Moreover, the blocking of the expression of Bcl-2 and PI3K significantly increased the level of apoptosis. Osthole and sorafenib successfully inhibited the migration of the MOGGCCM and T98G cells.https://www.mdpi.com/1420-3049/25/21/5192ostholeumbelliferoneesculin4-hydroxycoumarinsorafenibapoptosis
spellingShingle Joanna Sumorek-Wiadro
Adrian Zając
Ewa Langner
Krystyna Skalicka-Woźniak
Aleksandra Maciejczyk
Wojciech Rzeski
Joanna Jakubowicz-Gil
Antiglioma Potential of Coumarins Combined with Sorafenib
Molecules
osthole
umbelliferone
esculin
4-hydroxycoumarin
sorafenib
apoptosis
title Antiglioma Potential of Coumarins Combined with Sorafenib
title_full Antiglioma Potential of Coumarins Combined with Sorafenib
title_fullStr Antiglioma Potential of Coumarins Combined with Sorafenib
title_full_unstemmed Antiglioma Potential of Coumarins Combined with Sorafenib
title_short Antiglioma Potential of Coumarins Combined with Sorafenib
title_sort antiglioma potential of coumarins combined with sorafenib
topic osthole
umbelliferone
esculin
4-hydroxycoumarin
sorafenib
apoptosis
url https://www.mdpi.com/1420-3049/25/21/5192
work_keys_str_mv AT joannasumorekwiadro antigliomapotentialofcoumarinscombinedwithsorafenib
AT adrianzajac antigliomapotentialofcoumarinscombinedwithsorafenib
AT ewalangner antigliomapotentialofcoumarinscombinedwithsorafenib
AT krystynaskalickawozniak antigliomapotentialofcoumarinscombinedwithsorafenib
AT aleksandramaciejczyk antigliomapotentialofcoumarinscombinedwithsorafenib
AT wojciechrzeski antigliomapotentialofcoumarinscombinedwithsorafenib
AT joannajakubowiczgil antigliomapotentialofcoumarinscombinedwithsorafenib